Stay updated on BBI503 Combo with Anti-Cancer Agents Clinical Trial
Sign up to get notified when there's something new on the BBI503 Combo with Anti-Cancer Agents Clinical Trial page.

Latest updates to the BBI503 Combo with Anti-Cancer Agents Clinical Trial page
- Check3 days agoChange DetectedSite revision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check31 days agoChange DetectedRevision label updated from v3.4.3 to v3.5.0 on the page.SummaryDifference0.0%

- Check38 days agoChange DetectedRevision label updated from v3.4.2 to v3.4.3 and the previous label was removed.SummaryDifference0.0%

- Check67 days agoChange DetectedA new site revision note 'Revision: v3.4.2' appears; previous notices about government funding delays and 'Revision: v3.4.1' are removed.SummaryDifference0.4%

- Check74 days agoChange DetectedAdded a government funding notice with an NIH operations status update. Updated the site revision to v3.4.1, replacing the previous v3.4.0 note.SummaryDifference0.4%

- Check81 days agoChange DetectedThe page adds a 'Show glossary' option and includes minor metadata edits (such as QC criteria wording and revision notes) that do not affect the study content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

Stay in the know with updates to BBI503 Combo with Anti-Cancer Agents Clinical Trial
Enter your email address, and we'll notify you when there's something new on the BBI503 Combo with Anti-Cancer Agents Clinical Trial page.